SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.

Never miss a new study

Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear

Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2

Scientists test One-Time gene fix for devastating blood diseases

Disease control Recruiting now

This early-stage study is testing the safety of a new, one-time gene-editing treatment for people with severe sickle cell disease or beta-thalassemia. Doctors take a patient's own blood stem cells, edit a specific gene in the lab to boost healthy fetal hemoglobin, and then return…

Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Phase: PHASE1 • Sponsor: Daniel Bauer • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)

Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear

Scientists test One-Time gene fix for devastating blood diseases